Cloud-based imaging platform offering proprietary biomarkers for disease monitoring and analysis in clinical trials.

The world’s first quantitative imaging solution for the assessment of multi-organ tissue characteristics, function, and size using a single, non-contrast MRI scan. This noninvasive technology can support clinical decision-making by quantifying metrics from images of the heart, liver, lungs, kidneys, pancreas, and spleen.

Improving accuracy of liver health and volume assessment to support better pre-surgical decision making for patients with liver cancer.

LiverMultiScan is a noninvasive MRI scan that accurately assesses signs of liver disease, offering a complete picture of liver health.

MRCP+ provides enhanced visualization and quantitative assessment of the biliary tree and pancreatic duct, based on newly acquired or historic non-contrast MRCP images. This enables physicians to better evaluate and report on hepatobiliary structures for more accurate diagnosis, staging and monitoring of disease.